|
Space-Time Clustering
|
N05.715.360.750.746.500.500 |
|
|
Drug Liberation
|
G03.787.321 |
|
|
Sulfamoxole
|
D02.092.146.807.882 |
|
|
Sulfanilamide
|
D02.092.146.807.885 |
|
|
Suppressor of Cytokine Signaling 3 Protein
|
D12.776.476.024.437.750 |
|
|
Suppressor of Cytokine Signaling Proteins
|
D12.776.476.024.437 |
|
|
Communication Disorders
|
C23.888.592.604.150 |
|
|
Lyme Neuroborreliosis
|
C01.150.252.223.437 |
|
|
Central Nervous System Bacterial Infections
|
C01.150.252.223 |
|
|
Myofibrils
|
A11.284.430.214.190.750.620 |
|
|
Alpha-Amanitin
|
D12.644.456.050.111 |
|
|
Amanitins
|
D12.644.456.050 |
|
|
Rhizotomy
|
E04.525.210.815 |
|
|
Leigh Disease
|
C10.228.140.163.100.412 |
|
|
Echinococcosis
|
C01.610.335.190.396 |
|
|
Arterial Switch Operation
|
E04.100.376.031 |
|
|
Abducens Nerve Injury
|
C10.292.150.100 |
|
|
Nivolumab
|
D12.776.124.486.485.114.224.060.829 |
|
|
Sertoli-Leydig Cell Tumor
|
C04.588.945.440.915.500 |
|
|
Testicular Neoplasms
|
C04.588.945.440.915 |
|
